Snakebites and COVID-19: two crises, one research and development opportunity
Open Access
- 25 October 2021
- journal article
- editorial
- Published by BMJ in BMJ Global Health
- Vol. 6 (10), e006913
- https://doi.org/10.1136/bmjgh-2021-006913
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- On the road to Recovery—the world’s biggest covid-19 treatment trialBMJ, 2021
- Snakebite Envenoming Diagnosis and DiagnosticsFrontiers in Immunology, 2021
- Small Molecule Drug Discovery for Neglected Tropical SnakebiteTrends in Pharmacological Sciences, 2021
- Editorial: Novel Immunotherapies Against Envenomings by Snakes and Other Venomous AnimalsFrontiers in Immunology, 2020
- Global coalition to accelerate COVID-19 clinical research in resource-limited settingsThe Lancet, 2020
- Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenomingPLoS Neglected Tropical Diseases, 2019
- Current technology for the industrial manufacture of snake antivenomsToxicon, 2018
- Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?PLoS Neglected Tropical Diseases, 2015
- Snakebite and Its Socio-Economic Impact on the Rural Population of Tamil Nadu, IndiaPLOS ONE, 2013